GR70296B - - Google Patents

Info

Publication number
GR70296B
GR70296B GR51544A GR760151544A GR70296B GR 70296 B GR70296 B GR 70296B GR 51544 A GR51544 A GR 51544A GR 760151544 A GR760151544 A GR 760151544A GR 70296 B GR70296 B GR 70296B
Authority
GR
Greece
Application number
GR51544A
Original Assignee
Akzo Nv
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Akzo Nv filed Critical Akzo Nv
Publication of GR70296B publication Critical patent/GR70296B/el

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/2004—Excipients; Inactive ingredients
    • A61K9/2013—Organic compounds, e.g. phospholipids, fats
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
    • A61K9/4841—Filling excipients; Inactive ingredients
    • A61K9/4858—Organic compounds
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P5/00—Drugs for disorders of the endocrine system

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Public Health (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Diabetes (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Steroid Compounds (AREA)
GR51544A 1975-08-27 1976-08-25 GR70296B (el)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
NL7510104A NL7510104A (nl) 1975-08-27 1975-08-27 Werkwijze ter bereiding van een oraal werkzaam farmaceutisch preparaat.

Publications (1)

Publication Number Publication Date
GR70296B true GR70296B (el) 1982-09-06

Family

ID=19824362

Family Applications (1)

Application Number Title Priority Date Filing Date
GR51544A GR70296B (el) 1975-08-27 1976-08-25

Country Status (17)

Country Link
US (1) US4083973A (el)
JP (1) JPS5231063A (el)
AU (1) AU508727B2 (el)
BE (1) BE845613A (el)
CA (1) CA1092025A (el)
DE (1) DE2638507A1 (el)
FR (1) FR2321892A1 (el)
GB (1) GB1563302A (el)
GR (1) GR70296B (el)
HU (1) HU176743B (el)
IE (1) IE44533B1 (el)
IL (1) IL50274A (el)
LU (1) LU75648A1 (el)
NL (1) NL7510104A (el)
NZ (1) NZ181865A (el)
PH (1) PH12363A (el)
ZA (1) ZA764868B (el)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AT358530B (de) * 1978-04-25 1980-09-10 Plc Pharma Licences Stabilisierungsverfahren
FR2427100A1 (fr) * 1978-06-02 1979-12-28 Kali Chemie Pharma Gmbh Composition pharmaceutique a propriete de resorption amelioree et procede pour sa fabrication
EP0177342A3 (en) * 1984-10-04 1987-12-02 Genentech, Inc. Oral formulation of therapeutic proteins
US5140021A (en) * 1986-04-16 1992-08-18 Genesis Systems Corporation Method and dosage form for treatment of premenstrual syndrome
US5208032A (en) * 1988-07-15 1993-05-04 Rutgers, The State University Of New Jersey Increasing the growth of turkeys using implant of 19-nortestosterone
ATE333867T1 (de) * 1994-03-18 2006-08-15 Shire Lab Inc Emulgierte arzneistoffabgabesysteme
US5824638A (en) * 1995-05-22 1998-10-20 Shire Laboratories, Inc. Oral insulin delivery
US6011027A (en) * 1999-02-18 2000-01-04 Lpj Research, Inc. Use of 19-nor-4-androstenediol to increase 19-nortestosterone levels in humans
US6652880B1 (en) 1999-04-01 2003-11-25 R.P. Scherer Technologies, Inc. Oral pharmaceutical compositions containing long-chain triglycerides and liphophilic surfactants
US20040002482A1 (en) * 2000-08-30 2004-01-01 Dudley Robert E. Androgen pharmaceutical composition and method for treating depression
US6503894B1 (en) 2000-08-30 2003-01-07 Unimed Pharmaceuticals, Inc. Pharmaceutical composition and method for treating hypogonadism
US20040092494A9 (en) * 2000-08-30 2004-05-13 Dudley Robert E. Method of increasing testosterone and related steroid concentrations in women
CN1655770A (zh) 2002-04-25 2005-08-17 旗帜药物胶囊公司 可咀嚼的软胶囊
GB0304927D0 (en) * 2003-03-04 2003-04-09 Resolution Chemicals Ltd Process for the production of tibolone
ES2258694T3 (es) 2003-11-11 2006-09-01 Mattern, Udo Sistema de administracion de liberacion controlada de hormonas sexuales para aplicaciones nasales.
US8784869B2 (en) 2003-11-11 2014-07-22 Mattern Pharma Ag Controlled release delivery system for nasal applications and methods of treatment
CN1257711C (zh) * 2003-12-05 2006-05-31 石药集团中奇制药技术（石家庄）有限公司 丁苯酞软胶囊及其制备工艺
US20060140820A1 (en) 2004-12-28 2006-06-29 Udo Mattern Use of a container of an inorganic additive containing plastic material
US20070088012A1 (en) * 2005-04-08 2007-04-19 Woun Seo Method of treating or preventing type-2 diabetes
DK2450041T3 (en) 2005-10-12 2018-11-19 Unimed Pharmaceuticals Llc Enhanced testosterone gel for use in the treatment of hypogonadism
PL2068825T3 (pl) 2006-10-04 2011-06-30 M & P Patent Ag Układ dostarczania o kontrolowanym uwalnianiu do donosowego podawania związków neuroprzekaźnikowych
US9757388B2 (en) 2011-05-13 2017-09-12 Acerus Pharmaceuticals Srl Intranasal methods of treating women for anorgasmia with 0.6% and 0.72% testosterone gels
AR086400A1 (es) 2011-05-13 2013-12-11 Trimel Pharmaceuticals Corp Formulaciones en gel intranasal de testosterona en dosis de menor potencia y uso de las mismas para el tratamiento de la anorgasmia o el trastorno de deseo sexual hipoactivo
US20130045958A1 (en) 2011-05-13 2013-02-21 Trimel Pharmaceuticals Corporation Intranasal 0.15% and 0.24% testosterone gel formulations and use thereof for treating anorgasmia or hypoactive sexual desire disorder
US11744838B2 (en) 2013-03-15 2023-09-05 Acerus Biopharma Inc. Methods of treating hypogonadism with transnasal testosterone bio-adhesive gel formulations in male with allergic rhinitis, and methods for preventing an allergic rhinitis event
MX2016016612A (es) 2014-06-17 2017-03-20 Merck Sharp & Dohme Formulaciones estables de undecanoato de testosterona.

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2998423A (en) * 1958-02-25 1961-08-29 Organon Esters of 19-nortestosterone
US3016388A (en) * 1959-06-30 1962-01-09 Organon New esters of 19-nor-testosterone
US3400197A (en) * 1965-01-26 1968-09-03 Robins Co Inc A H Compressible sustained release pharmaceutical tablet lipid-colloidal silica gel matrix fragment granules
NL189235C (nl) * 1974-02-28 1993-02-16 Akzo Nv Werkwijze voor de bereiding van een oraal toe te dienen farmaceutisch preparaat met androgene werking.

Also Published As

Publication number Publication date
CA1092025A (en) 1980-12-23
HU176743B (en) 1981-05-28
GB1563302A (en) 1980-03-26
NZ181865A (en) 1978-12-18
DE2638507A1 (de) 1977-03-03
JPS5231063A (en) 1977-03-09
LU75648A1 (el) 1977-03-31
IL50274A (en) 1980-11-30
IL50274A0 (en) 1976-10-31
US4083973A (en) 1978-04-11
IE44533B1 (en) 1981-12-30
PH12363A (en) 1979-01-29
FR2321892B1 (el) 1979-05-25
FR2321892A1 (fr) 1977-03-25
ZA764868B (en) 1977-07-27
IE44533L (en) 1977-02-27
NL7510104A (nl) 1977-03-01
AU508727B2 (en) 1980-04-03
BE845613A (fr) 1977-02-28
AU1698076A (en) 1978-02-23

Similar Documents

Publication Publication Date Title
FR2321892B1 (el)
CH600606A5 (el)
CH595793A5 (el)
BG22093A1 (el)
BG22241A1 (el)
BG22270A1 (el)
BG22353A1 (el)
BG22534A1 (el)
BG23118A1 (el)
BG23124A1 (el)
BG23144A1 (el)
CH472175A4 (el)
CH575785A5 (el)
CH582320A5 (el)
CH586307A5 (el)
CH586956A5 (el)
CH588601A5 (el)
CH588994A5 (el)
CH589847A5 (el)
CH589973A5 (el)
CH590782A5 (el)
CH590789A5 (el)
CH591331A5 (el)
CH591961A5 (el)
CH600097A5 (el)